M. Weber

发表

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study.

D. Levy, W. Kannel, Daniel Levy, 1997, Circulation.

The role of post-mortem investigations in determining the cause of sudden unexpected death in infancy

N. Sebire, M. Ashworth, M. Weber, 2008, Archives of Disease in Childhood.

The neuropathological consequences of CDKL5 mutation

T. Jacques, P. Munot, P. Prabhakar, 2012, Neuropathology and applied neurobiology.

The first report of the Systolic and Pulse Pressure (SYPP) Working Group.

L. Kuller, G. Mancia, J. Cohn, 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?

L. Ruilope, G. Mcinnes, M. Volpe, 2005, Journal of Human Hypertension.

In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Kra

A. Gitt, M. Gottwik, J. Senges, 2005, Heart.

Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.

J. Laragh, J. Drayer, D. Case, 1976, The American journal of medicine.

Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.

J. Laragh, D. Case, M. Weber, 1977, The New England journal of medicine.

Antihypertensive Treatment: Considerations Beyond Blood Pressure Control

M. Weber, 1989, Circulation.

Circadian blood pressure patterns in ambulatory hypertensive patients: effects of age.

J. Drayer, M. Weber, F. Wyle, 1982, The American journal of medicine.

Contrasting clinical properties and exercise responses in obese and lean hypertensive patients.

M. Weber, D. Smith, J. Neutel, 2001, Journal of the American College of Cardiology.

Disparate Relationships Between Blood Pressure and Left Ventricular Mass in Patients With and Without Left Ventricular Hypertrophy

J. Gardin, J. Drayer, M. Weber, 1987, HYPERTENSION.

Controversies in the diagnosis and treatment of hypertension: a personal review of JNC V.

M. Weber, 1993, The American journal of cardiology.

Hypertension: steps forward and steps backward. The Joint National Committee fifth report.

J. Laragh, M. Weber, 1993, Archives of internal medicine.

Prazosin: Preliminary Report and Comparative Studies with Other Antihypertensive Agents

M. Weber, G. Stokes, 1974, British medical journal.

Comparison between moexipril and atenolol in obese postmenopausal women with hypertension.

M. Weber, M. Stimpel, B. Koch, 1996, Maturitas.

Impact of left ventricular hypertrophy on blood pressure responses to exercise.

V. Froelicher, J. Myers, M. Weber, 1992, The American journal of cardiology.

The adrenergic inhibitors.

J. Drayer, M. Weber, W. Graettinger, 1987, The Medical clinics of North America.

Treatment of isolated systolic hypertension with labetalol in the elderly.

T. Giles, M. Weber, J. Burris, 1990, Archives of internal medicine.

Evaluation of Labetalol in Elderly Patients with Essential Hypertension

M. Gregory, T. Giles, M. Weber, 1991, Journal of clinical pharmacology.

Assessment of renin dependency of hypertension with a dipeptide renin inhibitor.

H. Glassman, R. Luther, M. Weber, 1990, Circulation.

Angiotensin II receptor inhibition. A new therapeutic principle.

F. Messerli, M. Weber, H. Brunner, 1996, Archives of internal medicine.

Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial.

G. Bakris, J. de Champlain, I. Raz, 2007, Kidney international.

Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial

G. Bakris, A. Voors, I. Raz, 2006, Journal of Human Hypertension.

Mild hypertension in the elderly. A comparison of prazosin and enalapril.

S. Ricci, M. Weber, D. Cheung, 1989, The American journal of medicine.

Use of centrally-acting agonists in the treatment of mild hypertension in the elderly patient

J. Drayer, M. Weber, 1984 .

Is high blood pressure a late manifestation of the hypertension syndrome?

M. Weber, D. Smith, J. Neutel, 1999, American journal of hypertension.

Effects of sustained-release nicardipine on regression of left ventricular hypertrophy in systemic hypertension.

H. Dittrich, M. Ziegler, M. Weber, 1992, The American journal of cardiology.

Cardiovascular and metabolic characteristics of hypertension.

M. Weber, D. Smith, W. Graettinger, 1991, The American journal of medicine.

BP as a determinant of cardiac left ventricular muscle mass.

J. Drayer, M. Weber, J. L. DeYoung, 1983, Archives of internal medicine.

Assessment of left ventricular systolic and diastolic function with Doppler echocardiography in hypertensive patients receiving intravenous medroxalol.

J. Gardin, M. Weber, M. Knoll, 1990, American heart journal.

Lead-induced hypertension: possible role of endothelial factors.

E. Weiler, H. Gonick, M. Weber, 1993, American journal of hypertension.

Roundtable Discussion: Blood Pressure Lowering by Any Means, or Do Specific Medications Make a Difference?

T. Pickering, M. Moser, M. Weber, 2001, Journal of clinical hypertension.

Using placebo in hypertension clinical trials: new information and new opportunities

M. Weber, 2008, Journal of Human Hypertension.

The ethics of using placebo in hypertension clinical trials.

M. Weber, 1999, Journal of hypertension.

Translating data on antihypertensive drugs into clinical practice.

M. Weber, 1998, American journal of hypertension.

Unsolved problems in treating hypertension: rationale for new approaches.

M. Weber, 1998, American journal of hypertension.

Monotherapy with labetalol compared with propranolol. Differential effects by race.

B. Materson, F. Mcmahon, M. Weber, 1985, Journal of clinical hypertension.

Centrally Acting Antihypertensive Agents: A Brief Overview

J. Drayer, M. Weber, 1984, Journal of cardiovascular pharmacology.

Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.

A. Zanchetti, H. Black, J. Wittes, 1998, Controlled clinical trials.

P-wave configuration as an indicator of echocardiographic indices of cardiac structure and function in normotensive adolescents.

M. Weber, W. Graettinger, D. Cheung, 1990, Chest.

Renin subgroups in essential hypertension.

J. Laragh, J. Drayer, M. Weber, 1982, Clinical and experimental hypertension. Part A, Theory and practice.

Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines.

J. Laragh, J. Cohn, B. Materson, 1994, American journal of hypertension.

Histological examination in sudden unexpected death in infancy: evidence base for histological sampling

N. Sebire, M. Weber, M. Malone, 2011, Journal of Clinical Pathology.

Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS).

M. Gottwik, U. Tebbe, M. Weber, 1988, Journal of the American College of Cardiology.

Coagulation and inhibitory and fibrinolytic proteins in essential hypertension.

N. Vaziri, M. Weber, E. Gonzales, 1993, Journal of the American Society of Nephrology : JASN.

Left ventricular diastolic filling alterations in normotensive young adults with a family history of systemic hypertension.

M. Weber, D. Smith, J. Neutel, 1991, The American journal of cardiology.

Effect of the calcium channel blocker nitrendipine on left ventricular mass in patients with hypertension

W. White, V. Smith, W. Hall, 1986, Clinical pharmacology and therapeutics.

Reproducibility of the whole-day blood pressure pattern in essential hypertension.

J. Drayer, M. Weber, F. Wyle, 1982, Clinical and experimental hypertension. Part A, Theory and practice.

Low and High Renin Essential Hypertension: A Comparison of Clinical and Biochemical Characteristics

J. Laragh, J. Drayer, M. Weber, 1981, The American journal of the medical sciences.

Angiotensin blockade in studies of the feedback control of renin release in rats and rabbits.

M. Weber, G. Stokes, H. F. Oates, 1975, Clinical science and molecular medicine. Supplement.

Heredity and hypertension: impact on metabolic characteristics.

M. Weber, D. Smith, J. Neutel, 1992, American heart journal.

Hypertension with concomitant conditions: the changing role of beta-adrenoceptor blockade.

M. Weber, 1991, American heart journal.

Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.

J. Laragh, J. Drayer, D. Case, 1976, The American journal of medicine.

Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.

M. Weber, Michael A. Weber, 1997, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Hypertension in Patients with Diabetes Mellitus: Treatment with a Centrally Acting Agent

J. Drayer, M. Weber, M. Deitch, 1984, Journal of cardiovascular pharmacology.

Echocardiographic left ventricular hypertrophy in hypertension.

J. Gardin, J. Drayer, M. Weber, 1983, Chest.

Coronary heart disease and hypertension.

M. Weber, 1994, American journal of hypertension.

Beta-adrenoreceptor blockade in the conscious rabbit: effects on plasma renin activity and blood pressure.

M. Weber, G. Stokes, R. Graham, 1975, Life sciences.

Monotherapy of essential hypertension with a converting-enzyme inhibitor.

J. Drayer, M. Weber, 1983, Hypertension.

The Role of Renin in the Antihypertensive Action of β-Adrenoreceptor Blocking Agents

M. Weber, G. Stokes, R. Graham, 2012, Drugs.

Single-agent and combination therapy of essential hypertension.

J. Drayer, M. Weber, 1984, American heart journal.

A vasodilator that avoids renin stimulation and fluid retention: Antihypertensive treatment with trimazosin

W. Aronow, J. Drayer, M. Weber, 1982, Clinical pharmacology and therapeutics.

Renal effects of beta-adrenoceptor blockade.

J. Drayer, M. Weber, 1980, Kidney international.

Low‐dose diuretic and beta adrenoceptor blocker in essential hypertension

M. Weber, D. Brewer, M. Eltorai, 1980, Clinical pharmacology and therapeutics.

A physiological basis for the treatment of essential hypertension.

J. Laragh, M. Weber, 1978, Bulletin of the New York Academy of Medicine.

Renin reactivity as a determinant of responsiveness to antihypertensive treatment.

J. Laragh, J. Drayer, D. Case, 1977, Archives of internal medicine.

Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition.

M. Weber, D. Smith, J. Neutel, 1992, American heart journal.

Clinical safety and tolerability of losartan.

M. Weber, 1997, Clinical Therapeutics.

Enhancement of the pressor response to norepinephrine by angiotensin in the conscious rabbit.

J. Drayer, M. Weber, B. Ricci, 1985, Life sciences.

Effects of angiotensin II on pressor responses to norepinephrine in humans.

M. Weber, D. Smith, J. Neutel, 1991, Life sciences.

Comparative accuracy of three automated techniques in the noninvasive estimation of central blood pressure in men.

K. Lehmann, M. Weber, J. Gelman, 1998, The American journal of cardiology.

Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells.

E. Levin, A. Pedram, M. Weber, 1994, The Journal of biological chemistry.

The Effects of Clonidine and Propranolol, Separately and in Combination, on Blood Pressure and Plasma Renin Activity in Essential Hypertension

J. Laragh, J. Drayer, M. Weber, 1978, Journal of clinical pharmacology.

Disparate patterns of aldosterone response during diuretic treatment of hypertension.

J. Laragh, J. Drayer, M. Weber, 1977, Annals of internal medicine.

A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II).

J. Laragh, J. Drayer, D. Case, 1976, The New England journal of medicine.

Phentolamine testing for alpha adrenergic participation in hypertensive patients: Independence from renin profiles

J. Drayer, M. Weber, J. H. Laragh, 1977, Clinical pharmacology and therapeutics.

Catecholamine-mediated constrictor effects of aldosterone on vascular smooth muscle.

M. Weber, R. Purdy, Michael A. Weber, 1982, Life sciences.

Arterial compliance abnormalities in isolated systolic hypertension.

J. Cohn, S. Finkelstein, G. McVeigh, 2001, American journal of hypertension.

Documentation of the effective length of action of antihypertensive treatment.

M. Weber, 1990, The American journal of cardiology.

Characterization of antihypertensive therapy by whole-day blood pressure monitoring.

M. Weber, W. Graettinger, D. Cheung, 1988, JAMA.

Antihypertensive effects of beta-blockers administered once daily: 24-hour measurements.

M. Weber, J. Neutel, W. Graettinger, 1990, American heart journal.

Differential Effects of Diuresis and Beta‐Adrenoreceptor Blockade During Angiotensin‐Converting Enzyme Inhibition in Patients with Severe Hypertension

J. Drayer, M. Weber, J. Lipson, 1982, Journal of clinical pharmacology.

Cardiac muscle mass during vasodilation therapy of hypertension

J. Gardin, W. Aronow, J. Drayer, 1983, Clinical pharmacology and therapeutics.

The possible importance of aldosterone as well as renin in the long-term antihypertensive action of propranolol.

J. Laragh, J. Drayer, M. Weber, 1978, The American journal of medicine.

Interactions of Mineralocorticoids and Pressor Agents in Vascular Smooth Muscle

J. Drayer, M. Weber, R. Purdy, 1983, Hypertension.

Divergent blood pressure responses during short‐term sodium restriction in hypertension

J. Laragh, J. Drayer, M. Weber, 1980, Clinical pharmacology and therapeutics.

Incications and complications of invasive diagnostic procedures and percutaneous coronary interventions in the year 2003

M. Hochadel, M. Gottwik, U. Tebbe, 2005, Zeitschrift für Kardiologie.

Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report.

M. Weber, Michael A. Weber, 1992, American journal of hypertension.

Automated blood pressure monitoring: a new dimension in diagnosis.

M. Weber, 1988, Mayo Clinic proceedings.

Whole-day blood pressure.

M. Weber, 1988, Hypertension.

Applications of ambulatory blood pressure monitoring in clinical practice.

M. Weber, D. Smith, J. Neutel, 1991, Clinical chemistry.

Blood pressure in normal subjects

J. Drayer, M. Weber, 1990 .

Evaluating the diagnosis and prognosis of hypertension by automated blood pressure monitoring: outline of a symposium.

M. Weber, 1988, American heart journal.

Whole-day BP monitoring in ambulatory normotensive men.

J. Drayer, M. Weber, W. Hoeger, 1985, Archives of internal medicine.

Safety issues during antihypertensive treatment with angiotensin converting enzyme inhibitors.

M. Weber, 1988, The American journal of medicine.

Antihypertensive treatment with a dual-acting beta-blocker in the elderly.

J. Lessem, M. Weber, 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension.

J. Gardin, J. Drayer, M. Weber, 1983, The American journal of medicine.

Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction

M. Gottwik, J. Senges, U. Tebbe, 2004, Zeitschrift für Kardiologie.

Senges Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction ( ANTIBIO ) trial

M. Gottwik, U. Tebbe, S. Rosocha, 2004 .

Echocardiographic evaluation of left ventricular hypertrophy.

J. Drayer, M. Weber, W. Baird, 1986, Journal of cardiovascular pharmacology.

Blood pressure effects of the angiotensin II receptor blocker, losartan.

D. Snavely, E. Faison, E. Nelson, 1995, Archives of internal medicine.

Emerging treatments for hypertension: potential role for vasopeptidase inhibition.

M. Weber, Michael Weber, 1999, American journal of hypertension.

Measurement of short-term, intermediate, and long-term outcomes of treating hypertension.

M. Weber, P. Radensky, 1996, Cardiology clinics.

Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment.

V. Papademetriou, M. Weir, M. Weber, 1995, American heart journal.

Clinicopathological features of paediatric deaths due to myocarditis: an autopsy series

N. Sebire, M. Burch, M. Weber, 2008, Archives of Disease in Childhood.

Effects of indomethacin alone and during diuretic or beta-adrenoreceptor-blockade therapy on blood pressure and the renin system in essential hypertension.

J. Laragh, J. Drayer, M. Weber, 1978, Clinical science and molecular medicine. Supplement.

Evaluating risks and events in hypertension: an overview of the hypertension syndrome.

M. Weber, 1997, Journal of cardiovascular risk.

Effects of Beta-Adrenergic Antagonists and Diuretics on Kidney Function in Hypertensive Patients

J. Drayer, M. Weber, P. Kraut, 1984 .

Ambulatory blood pressure monitoring. Hypertensive Diseases Committee, American College of Cardiology.

W. White, S. Sheps, T. Pickering, 1994 .

Clinical Trials of Antihypertensive Agents

M. Weber, D. Smith, J. Neutel, 1990 .

Management of hypertensive patients with special problems.

M. Weber, 1989, The American journal of medicine.

Automated blood pressure monitoring for the assessment of antihypertensive treatment.

M. Weber, Michael A. Weber, 1988, The American journal of cardiology.

The challenge of very mild hypertension: should treatment be sooner or later?

S. Julius, M. Weber, 1998, American journal of hypertension.

Cardiovascular outcomes of treating high blood pressure.

M. Weber, 1987, American heart journal.

A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.

M. Weir, M. Weber, H. Punzi, 1992, Journal of human hypertension.

Characterization of a Low Molecular Weight Na‐K-ATPase Inhibitor of Urinary Origin

E. Weiler, H. Gonick, M. Weber, 1994, The American journal of the medical sciences.

Combined diuretic and sympatholytic therapy in elderly patients with predominant systolic hypertension.

J. Drayer, M. Weber, D. Gray, 1983, Chest.

Ambulatory blood pressure monitoring: clinical uses.

M. Weber, 1992, Hospital practice.

Hypertension in the elderly: 24 h ambulatory blood pressure results from a placebo-controlled trial.

M. Weber, D. Smith, J. Neutel, 1995, Journal of human hypertension.

Combination therapy with diuretics: an evolution of understanding.

H. Black, M. Weber, J. Neutel, 1996, The American journal of medicine.

Disparate responses of blood pressure to adrenergic stimuli during beta blockade.

J. Drayer, M. Weber, P. Frankfort, 1985, General pharmacology.

Antihypertensive agents which inhibit sympathetic activity: potentially adverse effects of combination treatment.

J. Drayer, M. Weber, 1982, American heart journal.

Automated ambulatory blood pressure monitoring: a study in age-matched normotensive and hypertensive men.

J. Drayer, M. Weber, D. Nakamura, 1985, American heart journal.

Effect of antihypertensive therapy on the circadian blood pressure pattern.

R. Klein, M. Weber, M. Tonkon, 1987, The American journal of medicine.

The use of short-term ambulatory blood pressure monitoring in differing forms of hypertension.

J. Drayer, M. Weber, J. L. DeYoung, 1983, Clinical and experimental hypertension. Part A, Theory and practice.

Atrial natriuretic factor-induced vasodepression occurs through central nervous system.

E. Levin, M. Weber, S. Mills, 1988, The American journal of physiology.

Clinical Efficacy of Eprosartan

M. Weber, 1999, Pharmacotherapy.

β-Blockers and Plasma Renin Activity in Hypertension

M. Weber, G. Stokes, I. R. Thornell, 1974 .

The circadian blood pressure pattern in ambulatory normal subjects.

J. Drayer, M. Weber, F. Wyle, 1984, The American journal of cardiology.

Blood Pressure Monitoring for Assessing the Duration of Action of Antihypertensive Treatment

R. Klein, M. Weber, M. Tonkon, 1987, Journal of clinical pharmacology.

Long-term BP monitoring in the evaluation of antihypertensive therapy.

J. Drayer, M. Weber, J. L. DeYoung, 1983, Archives of internal medicine.

Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilat.

R. Luther, M. Weber, J. Neutel, 1991, American heart journal.

The role of aldosterone in the response to treatment of primary hypertension.

J. Laragh, J. Drayer, M. Weber, 1982, Clinical and experimental hypertension. Part A, Theory and practice.

An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension

M. Weber, 1987, The Journal of the American Osteopathic Association.

A novel insulin mimetic without a proliferative effect on vascular smooth muscle cells.

A. Sidawy, B. Zhang, M. Weber, 2000, Journal of vascular surgery.

Tandem mass spectrometry findings at autopsy for detection of metabolic disease in infant deaths: postmortem changes and confounding factors

N. Sebire, S. Heales, M. Weber, 2011, Journal of Clinical Pathology.

Effects of sodium depletion on plasma renin activity and on the urinary excretion of cyclic AMP and aldosterone in hypoparathyroid patients.

M. Kleerekoper, M. Weber, G. Stokes, 1975, The Journal of clinical endocrinology and metabolism.

Role of routine neuropathological examination for determining cause of death in sudden unexpected deaths in infancy (SUDI)

B. Harding, T. Jacques, N. Sebire, 2011, Journal of Clinical Pathology.

Once-daily administration of acebutolol in treatment of hypertension.

J. Drayer, M. Weber, 1985, American heart journal.

Antihypertensive dose-response relationships: studies with the selective alpha 1-blocking agent terazosin.

R. Luther, M. Weber, A. Laddu, 1991, American heart journal.

ISOLATED UNILATERAL TUBEROUS SCLEROSIS-ASSOCIATED RENAL CYSTIC DISEASE IN A NEONATE

N. Sebire, M. Weber, R. Risdon, 2005, Fetal and pediatric pathology.

Prospective parental consent for autopsy research following sudden unexpected childhood deaths: a successful model

T. Jacques, N. Sebire, A. M. Taylor, 2009, Archives of Disease in Childhood.

Effects of beta adrenergic blocking agents on plasma renin activity in the conscious rabbit.

M. Weber, G. Stokes, I. R. Thornell, 1974, The Journal of pharmacology and experimental therapeutics.

Arterial properties of early hypertension.

M. Weber, D. Smith, W. Graettinger, 1991, Journal of human hypertension.

Hypertension as a risk factor syndrome: therapeutic implications.

M. Weber, 1993, The American journal of medicine.

Metabolic characteristics of hypertension: importance of positive family history.

M. Weber, D. Smith, J. Neutel, 1993, American heart journal.

The effect of antihypertensive drugs on vascular compliance

J. Sowers, M. Weber, N. Winer, 2001, Current hypertension reports.

P. Raskin, J. Wright, J. Pool, 1998, American journal of hypertension.

Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents.

V. Papademetriou, M. Lefkowitz, N. Kaplan, 1993, The American journal of medicine.

Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning.

M. Alderman, M. Weber, J. Neutel, 1996, American heart journal.

Diastolic blood pressure as a determinant of Doppler left ventricular filling indexes in normotensive adolescents.

J. Gardin, M. Weber, W. Graettinger, 1987, Journal of the American College of Cardiology.

Suppression of renin release by timolol.

M. Weber, G. Stokes, H. F. Oates, 1976, Archives internationales de pharmacodynamie et de therapie.

Virological investigations in sudden unexpected deaths in infancy (SUDI)

N. Sebire, M. Ashworth, M. Weber, 2010, Forensic science, medicine, and pathology.

Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal system.

J. Drayer, M. Weber, 1984, American heart journal.

The importance of pulsatile components of hypertension in predicting carotid stenosis in older adults

L. Kuller, K. Sutton-Tyrrell, S. Franklin, 1997, Journal of hypertension.

Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.

M. Weber, M A Weber, G. Stokes, 1974, The Journal of clinical investigation.

Diagnosis of mild hypertension by ambulatory blood pressure monitoring.

M. Weber, D. Smith, J. Neutel, 1994, Circulation.

Saralasin testing for renin-dependent hypertension.

M. Weber, 1979, Archives of internal medicine.

Common femoral artery ligation and local debridement: a safe treatment for infected femoral artery pseudoaneurysms.

R. Neville, C. Fox, A. Sidawy, 2001, Journal of vascular surgery.

Prevalence of carpal tunnel syndrome and wrist osteoarthritis in long-term paraplegic patients compared with controls

T. Bruckner, M. Weber, M. Akbar, 2014, The Journal of hand surgery, European volume.

Acute pharmacokinetic and hemodynamic effects of intravenous bolus dosing of nicardipine.

M. Weber, J. Neutel, D. Cheung, 1990, American heart journal.

Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension.

M. Weber, 1997, American journal of hypertension.

Hypertension in the aged: a pathophysiologic basis for treatment.

M. Weber, J. Neutel, J. Neutel, 1989, The American journal of cardiology.

Discontinuation Syndrome Following Cessation of Treatment with Clonidine and Other Antihypertensive Agents

M. Weber, 1980, Journal of cardiovascular pharmacology.

Rationalizing the treatment of hypertension.

M. Weber, Michael A. Weber, 2001, American journal of hypertension.

Doppler Echocardiographic Assessment of Left Ventricular Systolic and Diastolic Function in Mild Hypertension

J. Gardin, W. Henry, J. Drayer, 1987, Hypertension.

Beta-blockers and plasma renin activity in hypertension.

M. Weber, G. Stokes, I. R. Thornell, 1974, British medical journal.

Central and peripheral blockade of the sympathetic nervous system.

J. Drayer, M. Weber, 1984, The American journal of medicine.

Adverse effects of sudden withdrawal of antihypertensive medication.

M. Weber, F. Hubbell, 1980, Postgraduate medicine.

The Abrupt Discontinuation of Antihypertensive Treatment

M. Weber, F. Hubbell, D. Brewer, 1979, Journal of clinical pharmacology.

Renin and aldosterone suppression in the antihypertensive action of clonidine.

J. Laragh, J. Drayer, D. Case, 1976, The American journal of cardiology.

Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.

H. Black, W. White, W. Elliott, 1998, The American journal of cardiology.

Angiotensin receptor blockers and the cardiovascular continuum: what future is indicated by recent successes?

M. Weber, 2003 .

Staphylococcal toxins in sudden unexpected death in infancy: experience from a single specialist centre

N. Sebire, N. Klein, M. Weber, 2011, Forensic science, medicine, and pathology.

Gender Differences in Vascular Compliance in Young, Healthy Subjects Assessed by Pulse Contour Analysis

J. Sowers, M. Weber, N. Winer, 2001, Journal of clinical hypertension.

Severe hypertension induced by naloxone.

E. Levin, J. Drayer, M. Weber, 1985, The American journal of the medical sciences.

Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: a clinical experience trial. ACTION Study Investigators.

E. Michelson, M. Weir, M. Weber, 2000, American journal of hypertension.

Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril

G. Bakris, Alfonso T. Perez, W. White, 2013, Journal of Human Hypertension.

Relationship of left ventricular structure to maximal heart rate during exercise.

V. Froelicher, J. Myers, M. Weber, 1995, Chest.

Validation of portable noninvasive blood pressure monitoring devices: comparisons with intra-arterial and sphygmomanometer measurements.

M. Weber, M A Weber, W F Graettinger, 1988, American heart journal.

The evolving paradigm of hypertension.

M. Weber, 1995, Cardiology clinics.

Measuring hypertensive cardiovascular risk: the vascular overload concept.

S. Franklin, M. Weber, Stanley S. Franklin, 1994, American heart journal.

Comparison of bisoprolol with atenolol for systemic hypertension in four population groups (young, old, black and nonblack) using ambulatory blood pressure monitoring. Bisoprolol Investigators Group.

M. Weber, D. Smith, C. Ram, 1993, The American journal of cardiology.

Low Dose Oral and Transdermal Therapy of Hypertension

M. Weber, R. Kolloch, M. Drayer, 1985, Steinkopff.

Implications of a health lifestyle and medication analysis for improving hypertension control.

Purnima Chawla, G. Bakris, H. Black, 2000, Archives of internal medicine.

The sympathetic nervous system in primary hypertension.

J. Drayer, M. Weber, 1982, Mineral and electrolyte metabolism.

Twin born with a skeletonized hand in twin-to-twin transfusion syndrome treated with laser ablation in pregnancy

M. Weber, G. Smith, L. Garagnani, 2016, The Journal of hand surgery, European volume.

Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension

M. Weber, D. Smith, J. Neutel, 2006, Journal of Human Hypertension.

Comparative Antihypertensive Efficacy of Angiotensin Receptor Blocker‐Based Treatment in African‐American and White Patients

G. Bakris, W. White, T. Giles, 2005, Journal of clinical hypertension.

Biochemical cardiac risk factors during diuretic therapy.

M. Weber, F. Hubbell, R. Winer, 1982, Archives internationales de pharmacodynamie et de therapie.

Left ventricular hypertrophy and antihypertensive therapy.

M. Weber, W. Graettinger, 1992, American family physician.

The relationship of arterial compliance with endothelial-derived proteins of the hemostatic system.

N. Vaziri, M. Weber, E. Gonzales, 1993, Life sciences.

The effects of steroid hormones on vascular tissue.

J. Drayer, M. Weber, R. Purdy, 1984, Journal of cardiovascular pharmacology.

Comparisons in a competitive world: when is one drug superior to another?

C. Furberg, M. Weber, Michael A. Weber, 2000, American journal of hypertension.

Once-daily monotherapy with trandolapril in the treatment of hypertension.

H. Black, J. Schoenberger, M. Weber, 1996, Journal of human hypertension.

Effects of a human-derived sodium transport inhibitor on in vitro vascular reactivity.

E. Weiler, M. Weber, R. Purdy, 1989, American journal of hypertension.

Norepinephrine amplifies angiotensin II-induced vasoconstriction in rabbit femoral artery.

M. Weber, R. Purdy, B. Prins, 1992, Journal of Pharmacology and Experimental Therapeutics.

Extended‐release felodipine in patients with mild to moderate hypertension

D. A. Shapiro, E. Faison, E. Nelson, 1994, Clinical pharmacology and therapeutics.

The effects of benazepril, a new angiotensin‐converting enzyme inhibitor, in mild to moderate essential hypertension: A multicenter study

J. Mckenney, A. Leon, M. Sambhi, 1991, Clinical pharmacology and therapeutics.

beta-Adrenergic receptors and renin release: studies with beta-adrenoreceptor-blocking agents in the conscious rabbit.

M. Weber, G. Stokes, H. F. Oates, 1975, Clinical science and molecular medicine. Supplement.

Effect of chelation treatment with dimercaptosuccinic acid (DMSA) on lead-related blood pressure changes.

E. Weiler, M. Weber, R. Purdy, 1994, Environmental research.

Comparison of antihypertensive therapies by noninvasive techniques.

R. Klein, M. Weber, W. Graettinger, 1989, Chest.

Acute reversible renal impairment produced by a uricosuric diuretic.

M. Weber, F. Hubbell, D. Brewer, 1980, The Western journal of medicine.

Diazoxide-induced renin release in diagnosis of remediable renovascular hypertension.

A. Sheil, M. Weber, G. Stokes, 1976, Australian and New Zealand journal of medicine.

Definition of normalcy in whole-day ambulatory blood pressure monitoring.

J. Drayer, M. Weber, 1985, Clinical and Experimental Hypertension Part A Theory and Practice.

Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation.

J. Laragh, A. Zanchetti, S. Kjeldsen, 2001, Blood pressure.

Effects of low-dose antihypertensive therapy in elderly patients with predominant systolic hypertension.

J. Drayer, M. Weber, D. Gray, 1983, Journal of gerontology.

Low-dose combination therapy: an important first-line treatment in the management of hypertension.

M. Weber, J. Neutel, Michael Weber, 2001, American journal of hypertension.

Comparisons of the effects of different long-acting delivery systems on the pharmacokinetics and pharmacodynamics of diltiazem.

M. Weber, J. Neutel, D. Smith, 1999, American journal of hypertension.

A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning.

M. Weber, J. Neutel, D. Smith, 2001, American journal of hypertension.

Studies of the penetration of the blood brain barrier by atrial natriuretic factor.

E. Levin, M. Weber, M. Ismail, 1987, Biochemical and biophysical research communications.

Central nervous system mediated vasodepressor action of atrial natriuretic factor.

E. Levin, M. Weber, S. Mills, 1989, Life sciences.

TREATMENT OF HYPERTENSION WITH AN ANTIHYPERTENSIVE AGENT POSSESSING VASODILATOR ACTIVITY

M. Weber, G. Stokes, 1975, The Medical journal of Australia.

What are the approaches for evaluating antihypertensive treatment by 24 h ambulatory blood pressure monitoring?

M. Weber, J. Neutel, D. Smith, 1999, Blood pressure monitoring.

Place of Calcium Antagonists in Antihypertensive Therapy: Introduction and Round‐Table Discussion

J. Laragh, M. Weber, F. Bühler, 1984, Journal of cardiovascular pharmacology.

The evolution of antihypertensive therapy: current theoretical conditions and individualized treatment options.

M. Weber, 1992, The American journal of medicine.

HYPERTENSION SURVEY IN A CENTRAL CITY FREE CHEST X‐RAY CLINIC

M. Weber, G. Stokes, G. Bauer, 1973, The Medical journal of Australia.

A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension.

E. Fletcher, S. Grandy, M. Weber, 1994, American journal of hypertension.

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

J. Laragh, A. Zanchetti, S. Kjeldsen, 2004, The Lancet.

Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy.

V. Papademetriou, M. Weir, M. Weber, 1996, American journal of hypertension.

Comparative Antihypertensive Efficacy of Angiotensin Receptor Blocker‐Based Treatment in African‐American and White Patients

G. Bakris, W. White, T. Giles, 2005, Journal of clinical hypertension.

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

J. Laragh, A. Zanchetti, S. Kjeldsen, 2004, The Lancet.

Interactions of Mineralocorticoids and Pressor Agents in Vascular Smooth Muscle

J. Drayer, M. Weber, R. Purdy, 1983, Hypertension.

Diastolic blood pressure and left ventricular filling.

R. Klein, M. Weber, W. Graettinger, 1988, American Journal of Hypertension.

Assessing duration of antihypertensive effects with whole-day blood pressure monitoring.

M. Weber, D. Cheung, J. L. Gasster, 1989, Archives of internal medicine.

Effects on the renin-angiotensin system of agents acting at central and peripheral adrenergic receptors.

J. Drayer, M. Weber, F. Hubbell, 1983, Chest.

Saturday, 25 August 2012

H. W. Lee, M. Morello, B. Geršak, 2012 .